Course Exam
301908 VO Development of novel cancer immunotherapies (2022S)
from target identification through target validation to clinical trials
Labels
ON-SITE
WHEN?
Monday
26.09.2022
14:30 - 16:30
BZB/Seminarraum 1/2, 6.Ebene 6.501/6.504, Dr.-Bohr-Gasse 9, 1030 Wien
Registration/Deregistration
Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
- Registration is open from Tu 01.03.2022 09:00 to Su 25.09.2022 09:00
- Deregistration possible until Su 25.09.2022 09:00
Examiners
Information
Assessment and permitted materials
Written exam, alternative: presentation
Minimum requirements and assessment criteria
Understanding of the basic mechanisms of resistance development and of newest technologies
Last modified: Th 09.06.2022 09:49